Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A 'fault' in the cellular power plant explains the abnormal metabolism of tumours

24.10.2007
The increased consumption of glucose that tumour cells exhibit, was thought to be a cause of the extra demand of building blocks required to keep up with an uncontrolled cell growth, but now it is more accepted that it could be the effect of a programmed metabolic change that favours this malignant growth.

The German Nobel laureate Otto Warburg, one of twentieth century's leading scientists observed that tumour cells exhibit an increased aerobic glucose metabolism in their glycolysis process.

Seeing that, Warburg concluded that cancer should be interpreted as a mitochondrial dysfunction, but his hypothesis was not accepted at the time, and was forgotten by the scientific community until it was recently experimentally confirmed, arousing great interest in biotechnological and pharmaceutical companies.

The comeback of Warburg's hypothesis has been greatly helped by the research of a group of Spanish physicians and scientists from the “12 de octubre” hospital in Madrid (López-Ríos, García-García, Pozo-Rodriguez, López-Encuentra and Ballestín) and from the “Universidad Autónoma de Madrid” (Sanchéz-Aragó, Ortega y Berrendero) under the direction of José Manuel Cuezva, professor of biochemistry and molecular biology at the “Centro de Biología Molecular Severo Ochoa”.

... more about:
»Glucose »tumour

Their latest research work, recently published in the prestigious journal Cancer Research, describes how the activity or expression of the protein beta-F1-ATPase (responsible for the synthesis of ATP) that controls the aerobic usage of glucose in a cell, shows an inverse correlation between the glycolysis process and the metabolic energy supply of mitochondria.

The study carried out by Dr. Cuezva´s team focused on lung cancer patients. The increase in glucose capture by the tumours was measured using Positron emission tomography (PET), and then contrasted with the expression of protein beta-F1-ATPase, determined from the tumours obtained after surgery, finding an inverse correlation between the two variables.

They also describe in their research work, that when the beta-F1-ATPase protein expression is inhibited or its activity reduced in the carcinomas, the tumour cells are forced to increase their intake of glucose by glycolytic means. Although this research trend is not new, since this same team already has reported in earlier work how the disruption of the mitochondrial bioenergetic function is a metabolic signature of tumours, and how this could be used in clinical prognosis of patients with colorectal, lung or breast cancer. Among other applications that the team and other research groups consider promising are the uses of this signature as a tool to predict the reaction of a patient to a treatment, or as a therapeutic target against cancer.

The commercial applications of such prospective therapies are already protected by a patent that is owned by the “Universidad Autónoma de Madrid” and is licensed to the Spanish biotechnology firm “Fina Biotech, S.L”. Therefore this study might not sound like a new scientific discovery, but it provides the first evidence that integrates molecular and functional data supporting Warburg's hypothesis emphasizing the importance of the mitochondria in human pathology and more specifically in cancer biology.

Oficina de Cultura Científica | alfa
Further information:
http://dx.doi.org/10.1158/0008-5472.CAN-07-1678

Further reports about: Glucose tumour

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>